B Vangerow
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Hemodynamic Monitoring and Therapy, Sepsis Diagnosis and Treatment, Trauma, Hemostasis, Coagulopathy, Resuscitation, Muscle and Compartmental Disorders, Xenotransplantation and immune response
Most-Cited Works
- → Hydroxyethyl starch and modified fluid gelatin maintain plasma volume in a porcine model of septic shock with capillary leakage(2002)97 cited
- → Evaluation of noninvasive determinants for capillary leakage syndrome in septic shock patients(2000)91 cited
- → Acute vascular rejection is associated with systemic complement activation ina pig‐to‐primate kidney xenograft model(2000)62 cited
- → Predictors of respiratory function deterioration after transfer of critically ill patients(1998)50 cited
- → Compositional, structural, and functional alterations in pulmonary surfactant in surgical patients after the early onset of systemic inflammatory response syndrome or sepsis(1999)26 cited
- → Xenon inhalation increases airway pressure in ventilated patients(1999)18 cited
- → Septic shock after liver transplantation for Caroli's disease: clinical improvement after treatment with C1-esterase inhibitor(1999)17 cited
- → Low‐dose dopexamine in patients undergoing hemihepatectomy: an evaluation of effects on reduction of hepatic dysfunction and ischaemic liver injury(2000)12 cited
- → Terminal complement complex in septic shock with capillary leakage(2005)10 cited
- → C1 Inhibitor for Prophylaxis of Xenograft Rejection After Pig to Cynomolgus Monkey Kidney Transplantation. Transplantation 2002: 73: 688.(2002)9 cited